greeksoup/ stock research

Medtronic (MDT) FY2022 results: revenue $31.7 billion, up 5.2% on the year

Medtronic plc (MDT) reported revenue of $31.7 billion for fiscal 2022, the year ended 29 April 2022, up 5.2% on the year before. Net income was $5.0 billion, up 39.7%, and diluted earnings per share $3.73. The figures are the company's own, from the 10-K it filed with the SEC on 23 June 2022.

Revenue
$31.7 billion
+5.2% on the year
FY2015FY2022
Operating margin
18.2%
14.9% a year earlier
FY2015FY2022
Net income
$5.0 billion
+39.7% on the year
FY2015FY2022
Diluted EPS
$3.73
+40.2% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue31,68630,11728,913+5.2%
Cost of revenue10,14510,4839,424-3.2%
Gross profit21,54119,63419,489+9.7%
Gross margin68.0%65.2%67.4%
Research and development2,7462,4932,331+10.1%
Selling, general and administrative10,29210,14810,109+1.4%
Operating income5,7524,4844,791+28.3%
Operating margin18.2%14.9%16.6%
Interest expense5539251,092-40.2%
Pre-tax income5,5173,8954,055+41.6%
Income tax456265-751+72.1%
Effective tax rate8.3%6.8%-18.5%
Net income5,0393,6064,789+39.7%
Net margin15.9%12.0%16.6%
Diluted EPS$3.73$2.66$3.54+40.2%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow7,3466,2407,234+17.7%
Capital expenditure1,3681,3551,213+1.0%
Free cash flow5,9784,8856,021+22.4%
Free cash flow margin18.9%16.2%20.8%
Cash from investing-1,659-2,866-3,203
Cash from financing-5,336-4,136-4,198
Depreciation and amortisation2,7072,7022,663+0.2%
Share-based compensation359344297+4.4%
Buybacks2,5446521,326+290.2%
Dividends paid3,3833,1202,894+8.4%
Dividend per share$2.52$2.32$2.16+8.6%
Diluted shares, weighted1,351m1,354m1,351m-0.2%
Shares outstanding at period end1,331m1,345m1,341m-1.1%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity52,55151,42850,737+2.2%
Non-controlling interest171174135-1.7%
Debt24,11426,37824,916-8.6%
Operating lease liabilities703829774-15.2%
Finance lease liabilities56.062.045.0-9.7%
Other liabilities13,38614,21214,082-5.8%
Total liabilities and equity90,98193,08390,689-2.3%
Fixed assets5,4135,2214,828+3.7%
Goodwill40,50241,96139,841-3.5%
Intangible assets15,59517,74019,063-12.1%
Investments6,8597,2246,808-5.1%
Cash and equivalents3,7143,5934,140+3.4%
Receivables5,5515,4624,645+1.6%
Inventory4,6164,3134,229+7.0%
Other assets8,7317,5697,135+15.4%
Total assets90,98193,08390,689-2.3%

10-K for the year ended 29 April 2022, filed 23 June 2022: the filing.